Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Khiron Life Sciences Corp KHRWF


Primary Symbol: V.KHRN.H Alternate Symbol(s):  V.KHRN.W.H | KHRNF

Healthcare Cannabis
Khiron Life Sciences Corp. is a Canada-based medical cannabis company with core operations in Latin America. The Company has its wholly owned medical health clinics and telemedicine platforms. The Company has two product lines: Medical Cannabis Products and Health Services. It sells branded medical cannabis products to patients with medical conditions. Under the Medical Cannabis Products line... see more

Bullboard (TSXV:KHRN.H)

View:
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 Next
Comment by Chal112on Feb 21, 2020 7:57pm

RE:Cash vs. Market Cap

dont overly discount the value of Kuida.  Look out for surprising sales number in April for the brand.
120
Discussion
Comment by JustAnotherLongon Feb 21, 2020 4:52pm

RE:Cash vs. Market Cap

I worked out it got to 85% down from the absolute 12 month high. Even if it only retraces to 75% down that's $1.20 per share.
124
Discussion
Post by haunsoloon Feb 20, 2020 3:26pm

Cash vs. Market Cap

So we don't know the current cash balance but it should be about $40 million CDN. Market cap is currently $75 million CDN, so the company minus cash is valued at $35 million CDN. Don't know ...more  
333
Discussion
Post by Liscomorris1on Feb 20, 2020 10:24am

In the news

KHRN expands further into European market with https://ca.finance.yahoo.com/news/khiron-announces-plans-expand-kuida-130400312.html
108
Comment by Ziptrainon Feb 18, 2020 7:59pm

RE:Kuida products flying off the shelves in Colombia

Almost a dozen products hitting the shelves and selling out... wow... thx for the information. Let us know if you finally find product available. Good Day
127
Discussion
Post by Chal112on Feb 18, 2020 9:42am

Kuida products flying off the shelves in Colombia

My second home is Colombia and I am here now.  Been shopping at all the major pharma chains for Kuida products and all stores are telling me they have sold out.  Very high demand for these ...more  
366
Discussion
Post by Anonymous01on Feb 15, 2020 6:23pm

Friday's Selling was MJ ETF Rebalance ... FYI

Credit Suisse executed the MJ ETF rebalance, some names were bought, others sold.
175
Post by wreakhavokon Feb 14, 2020 4:42pm

A Fine Fine Kettle of Fish

Crazy!  ...half the price from one month ago!  Definitely driven down by Anonymous, but now in the bargain basement. Waiting on Mexican legalization.  When that happens...it's off ...more  
287
Discussion
Comment by JustAnotherLongon Feb 14, 2020 4:36pm

RE:RE:Khiron Life Sciences To Conduct Share Buybacks

That should read "NOT paying LABS (Medipharm) almost 10mill".  D'oh!
134
Discussion
Comment by JustAnotherLongon Feb 14, 2020 4:35pm

RE:Khiron Life Sciences To Conduct Share Buybacks

Knocked down 10c since that announcement so at least they'll do this buyback on the cheap.  On the flipside it's not going bounce the stock above the old 52 week low. Sentiment for pot ...more  
191
Discussion
Comment by RoadRunner123on Feb 13, 2020 12:44pm

RE:RE:RE:UM ... 45 milion in cash and 77 M market cap = Way Oversold

Looks like from last quarterly numbers and the Canaccord report for the quarter that the cash burn is being managed and reduced. I would expect this trend to continue as management streamlines ...more  
230
Discussion
Post by ORTsnorton Feb 13, 2020 9:49am

LOL!!! sold assets? NAW almost 45 M n the bank

Weak attempt Bruh!!   Solid cash sitting the bank here!!  This is the only POT stock out there with cash and no debt and financed out for a while!!   I am buying more today!! HAHAHAHA!! ...more  
192
Comment by KingTigeron Feb 13, 2020 7:59am

RE:Big money accumulate.

Khiron is dead in the water sold assets I bet to have cash to do a share buy back
152
Discussion
Comment by Kyle2020on Feb 12, 2020 9:32pm

RE:RE:UM ... 45 milion in cash and 77 M market cap = Way Oversold

LickMorris, respectfully, I warned of this range repeatedly months ago, much to your anger....I thought we would hit .60 in December so was slightly off. They do not have 45m in cash at this stage ...more  
262
Discussion
Comment by Blackbearon Feb 12, 2020 2:37pm

RE:RE:UM ... 45 milion in cash and 77 M market cap = Way Oversold

Especially the fumbling in ontario, canadas biggest market...now that was not planned very well at all....no stores equals no sales
125
Discussion
Prev ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities